Topic: AS08-Treatment/AS08a-Current treatment options – Higher risk MDS: VENETOCLAX AND AZACYTIDINE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES, A REAL-WORLD EXPERIENCE. LATIN-AMERICAN MDS GROUP – GLAM. (May 2023) - Iastrebner, M.; Crisp, R.; Ovilla, R.; Enrico, A.; De Leon, A. Gomez; Varela, A.; Velloso, E.; Puente, A.; Duarte, F.; Gusmao, B. Moreno; Schusterschitz, S.; Wernicke, P.; et al.